- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Becton Dickinson (NYSE: BDX) hit a new 52-week high Wednesday as it is currently trading at $92.61, above its previous 52-week high of $92.60 with 351,306 shares traded as of 1:48 p.m. ET. Average volume has been 1.1 million shares over the past 30 days. Becton Dickinson has a market cap of $17.82 billion and is part of the health care sector and health services industry. Shares are up 17.3% year to date as of the close of trading on Tuesday. Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. The company has a P/E ratio of 16.7, below the S&P 500 P/E ratio of 17.7.